A new tablet doubles the life expectancy in females with lung cancer and is regarded as the 'most exciting types of treatments' so far. The pill, crizotinib, is known to act on a specific cancer gene mutation, chiefly found in females in the age group of 30 to 50 years. It blocks the cancer cell signals and prevents further spread of the cancer. Prof. Katia Boleti, Consultant Oncologist at the Royal Free Hospital in London, mentioned, "These ...
via Medindia Health News More READ
via Medindia Health News More READ
No comments:
Post a Comment